Gene Query: SCNM1

Dataset Description Geneva Score
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 35.93
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 19.83
Tracking of dCas9-methyltransferase footprints 16.89
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 14.82
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 13.73
HNF1A deficiency impairs β-cell fate, granule maturation and function 13.54
DART-seq: an antibody-free method for global m6A detection 13.26
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 13.03
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 12.08
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 12.08
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 11.88
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.24
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.86
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 10.19
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 9.88
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 9.84
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 9.75
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 9.65
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 9.65
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.04
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.04
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.86
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.55
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 8.27
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.12
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.12
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 8.08
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.9
SETBP1-WT and SETBP1-G870S epigenetic landscapes 7.66
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 7.66
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.56
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.5
CROP-Seq in Primary Human T Cells 7.43
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.32
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.3
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.19
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 7.19
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 7.19
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.88
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.87
Transcriptional profiling of microglia; current state of the art and future perspectives 6.8
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.64
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.54
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.42
Impact of dieldrin on transcription in Jurkat T cells 6.42
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.21
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.15
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.11
Short and Long RNA sequencing of human mature erythrocytes 6.04
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.01
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.0
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.94
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.93
scRNASeq analysis of cycling cardiomyocytes 5.93
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.93
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.93
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.83
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.81
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.6
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.59
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.57
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.55
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.45
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.42
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.41
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.29
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 5.24
Identification of renal resident macrophages across species 5.23
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.22
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 5.22
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 5.22
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.15
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.15
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 5.04
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.0
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.93
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.93
Global analysis of enhancer targets: Mosaic-seq 4.9
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.88
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.86
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.77
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.76
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.7
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.7
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.65
Direct Isolation and Characterization of Human Nephron Progenitors. 4.63
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 4.63
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.6
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.58
Global transcriptome analysis of HAP1 cells 4.58
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.57
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.49
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.49
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.45
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.41
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 4.41
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 4.41
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.39
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.37
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.36
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 4.3
U1 snRNP telescripting regulates size-function stratified human genome 4.23
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.22
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.22
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.22
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.11
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.01
Effect of disulfiram treatment on pediatric high grade glioma 4.0
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.96
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.93
Unique features and clinical importance of acute alloreactive immune responses 3.9
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.84
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.81
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.8
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 3.8
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.77
Gene expression changes associated with resistance to tagraxofusp (SL-401) 3.76
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 3.72
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.71
Human Treg IL-12 stimulation 3.71
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.69
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.69
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.64
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.64
Effect of from Human Umbilical Vein Endothelial Cells 3.6
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.57
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 3.57
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 3.56
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.56
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.56
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.53
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.53
RNA-seq analysis of AML cells in response to ASLAN003 3.49
DRB/GRO-Seq -/+ UV 3.48
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.48
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.48
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 3.44
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 3.41
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 3.41
Silencing p300 in MCF7 cells to study expression and alternative splicing 3.38
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.37
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.37
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.37
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.36
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.35
Expression data from miR340 overexpressing human A549 cells 3.35
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.34
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.34
miRNAs affected by antagomiR-17 treatment 3.33
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.3
mRNA expression profile of Lymphocytes 3.3
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.27
hTERT promotes cell adhesion and migration independent of telomerase activity 3.23
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.22
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 3.2
RNA-seq analyisis of PUM2 knockout cells 3.2
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.18
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 3.17
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.16
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.16
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 3.15
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.15
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.12
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 3.08
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.08
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 3.06
RNA-seq analysis upon ARID1B overexpression 3.05
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.99
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.97
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.96
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.96
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.93
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.92
Differential gene expression of human melanoma cells [RNA-seq] 2.91
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.91
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.91
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.91
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 2.91
Lysine benzoylation is a novel histone mark 2.9
Lysine benzoylation is a novel histone mark [RNA-seq] 2.9
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.88
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.85
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.85
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.85
IDH3a KO RNA-seq 2.84
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.83
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.83
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.82
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.82
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.81
Cajal bodies are linked to genome conformation 2.77
Cajal bodies are linked to genome conformation [RNA-Seq] 2.77
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.77
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 2.77
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.76
Transcriptional landscape changes during human embryonic stem cell derivation 2.75
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.74
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.74
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.71
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.68
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.67
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.63
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.61
Functional significance of the HIV-1 Tat signature amino acid residues 2.61
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.6
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 2.59
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 2.57
MicroRNA-125a-5p overexpression in human macrophages 2.56
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.55
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.51
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.5
Active translatome profiling with RiboLace in MCF7 cells 2.5
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.5
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.49
Single cell transcriptome of peritoneal cells 2.49
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.48
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.47
m6A-dependent regulation of messenger RNA stability 2.46
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 2.45
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.44
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 2.44
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 2.44
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.39
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.39
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.39
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.39
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.39
TT-Seq captures the human transient transcriptome 2.38
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.38
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.37
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.37
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.37
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.35
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.35
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 2.34
SLAM-seq for K562 endogenous mRNA decay 2.33
RNA-seq differential expression studies: more sequence, or more replication? 2.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.32
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.32
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.31
A map of gene expression in neutrophil-like cell lines 2.31
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.31
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.3
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 2.29
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.27
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.26
Targeting MTHFD2 in Acute Myeloid Leukemia 2.25
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.24
RNAseq of cell lines with knocked in ESR1 mutations 2.22
Transcriptome sequencing of K-562 cells 2.2
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.18
NR2F2 study 2.18
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.18
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.16
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.15
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 2.14
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.14
Paxillin regulates genomic networks in prostate cancer [PC3] 2.13
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.13
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.12
Effect of drugs on transcriptomic profiles 2.11
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.11
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.1
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.1
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.09
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.06
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.06
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 2.06
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.05
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.02
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.0
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.0
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 2.0
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.99
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.97
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.97
Gene expression analysis upon mtDNA depletion 1.97
MCF-7 as a model for functional analysis of breast cancer risk variants 1.95
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.94
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.93
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.92
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.91
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.9
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.9
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.89
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.89
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.88
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 1.86
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 1.84
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.84
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.82
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 1.82
U2AF1 mutations alter splice site recognition in hematological malignancies 1.78
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.76
MARCKS and lnc-MARCKS act as inflammation regulators 1.73
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.7
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.68
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 1.68
Chromatin-informed inference of transcriptional programs in gynecologic cancers 1.63
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 1.63
Gene expression signatures of innate lymphoid cells from human blood 1.63
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.63
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.62
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.62
Regulatory network controlling tumor-promoting inflammation in human cancers 1.62
H1609088 Human RNA-Sequencing 1.62
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.62
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.6
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.6
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.58
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.58
The transcriptome effect of overexpressing EZH2 in MCF7 1.57
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.56
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.55
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.55
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.55
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.55
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.54
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.54
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.52
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.52
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.49
Transcription control by the ENL YEATS domain in acute leukemia 1.49
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.49
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.48
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.48
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.46
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.45
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.44
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.43
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.42
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.42
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.37
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.36
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.34
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.34
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.33
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.32
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.32
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.29
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.29
Genes significantly down or Up-regulated upon RNF219 knockdown 1.27
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.24
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 1.24
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.23
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.23
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.21
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.21
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.2
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.2
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.2
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.2
High-throughput sequencing of pluripotent cells 1.16
Transcriptome-wide modulation of splicing by the exon junction complex 1.16
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.16
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.14
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.14
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.13
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.13
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.06
Metastasis in triple-negative breast cancer 1.06
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.06
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.04
Transcriptome of diurnal human blood neutrophils 1.03
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.02
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.0
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.0
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.99
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.98
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.97
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.97
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.96
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.96
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.93
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 0.93
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.93
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.93
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.93
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.91
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.89
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.85
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.85
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.85
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.83
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.82
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.82
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.81
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.81
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.81
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 0.8
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.8
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.79
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.78
RNAseq analysis of ruxolitinib treated breast cancers 0.77
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.77
Loss of CREBBP results in gene expression repression in lymphoma cells 0.77
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.76
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.76
Effect of ILF3 on translation during homeostasis and the antiviral response 0.75
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.74
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.73
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.72
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.71
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.71
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.71
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.68
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.68
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.67
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.66
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.66
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.66
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.66
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.65
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.65
O-glcnAc reprograms cellular energetics 0.63
Transcriptomic analyssis following EHMT1/2 inhibition 0.62
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 0.59
Irf9 function in immunity in mouse 0.59
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.58
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.58
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.57
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.54
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.53
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.53
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.52
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.52
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.52
Transcriptome analysis of SKI knock-out in HL60 cells 0.51
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.51
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.49
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.47
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.47
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.47
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.45
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.44
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.44
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.42
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.42
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.42
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.41
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.4
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.4
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.4
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.4
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.4
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.4
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.39
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.38
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.37
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.37
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.37
Hepatic transcriptome of pediatric hepatoblastoma. 0.36
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.35
mRNA recovered upon RNF219 IP. [RNA-IP] 0.33
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.31
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.3
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.29
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.29
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.27
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.27
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.27
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.26
Expression analysis of the TAF1 syndrome 0.25
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.25
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.23
Measure transcript integrity using RNA-seq data 0.2
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.19
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.18
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.17
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.15
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.14
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.14
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.13
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.13
AUF-1 affected genes in human skin cells 0.12
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.12
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.11
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.11
The cohesin complex prevents Myc-induced replication stress 0.11
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.1
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.09
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.08
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.08
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.07
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.06
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.06
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.06
Role of COP1 on MAP kinase transcriptional output in melanoma 0.05
High-resolution comparative analysis of great ape genomes 0.05
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.03
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.01
RNA-seq data 0.01
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.01
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation